Instant automatic diagnosis of diabetic retinopathy
0
🚀
Sign in to get full access
Overview
- The study aims to evaluate the performance of the OphtAI system for automatically detecting referable diabetic retinopathy (DR) and assessing DR severity using color fundus photography.
- OphtAI uses ensembles of convolutional neural networks to recognize eye laterality, detect referable DR, and assess DR severity.
- The system was developed and validated using a large dataset of 763,848 images from 164,660 screening procedures, and also evaluated on the public Messidor-2 dataset.
Plain English Explanation
The OphtAI system is designed to automatically analyze color images of the back of the eye (called fundus images) to detect signs of a eye disease called diabetic retinopathy (DR). DR is a complication of diabetes that can damage the blood vessels in the back of the eye and lead to vision loss if not caught and treated early.
The researchers trained machine learning models within the OphtAI system to look for specific patterns in the fundus images that indicate the presence and severity of DR. The system can not only detect whether DR is present and needs further medical attention, but it can also assess how advanced the DR is.
To develop and test the OphtAI system, the researchers used a very large dataset of over 760,000 fundus images from nearly 165,000 patient screening sessions. They also evaluated the system on another publicly available dataset called Messidor-2. The results showed that OphtAI can detect referable DR (DR that requires medical treatment) with very high accuracy, outperforming the only other AI system currently authorized for this purpose by the FDA. The OphtAI system can also accurately detect more advanced, vision-threatening forms of DR.
A key benefit of the OphtAI system is that it can provide an instant diagnosis, which could help streamline DR screening and make it more accessible for people with diabetes. This is important because DR is a leading cause of vision loss, but early detection and treatment can prevent most vision problems.
Technical Explanation
The OphtAI system uses ensembles of convolutional neural networks to automatically recognize eye laterality, detect referable diabetic retinopathy (DR), and assess DR severity based on color fundus photography.
The system was developed and validated using a large dataset of 763,848 images from 164,660 screening procedures from the OPHDIAT screening program. It was also evaluated on the public Messidor-2 dataset for comparison purposes.
On the Messidor-2 dataset, OphtAI achieved an area under the ROC curve (AUC) of 0.989 for detecting referable DR using the University of Iowa's reference standard (95% CI: 0.984-0.994). This outperforms the only other AI system authorized by the FDA, which had an AUC of 0.980 under the same conditions.
The OphtAI system can also detect vision-threatening DR with an AUC of 0.997 (95% CI: 0.996-0.998) and proliferative DR with an AUC of 0.997 (95% CI: 0.995-0.999). The system runs in 0.3 seconds using a graphics processing unit (GPU) and less than 2 seconds without a GPU.
Critical Analysis
The study provides a comprehensive evaluation of the OphtAI system's performance in detecting referable DR and assessing DR severity. The use of a very large, diverse dataset for training and validation, as well as the comparison to the FDA-authorized AI system, lends strong credibility to the results.
However, the paper does not provide much detail on the specific model architectures or training procedures used for the convolutional neural networks within OphtAI. Additionally, while the reported performance metrics are excellent, the paper does not discuss any potential limitations or edge cases that the system may struggle with.
Further research could explore the system's robustness to factors like image quality, patient demographics, or differences in screening protocols across healthcare settings. Evaluating the system's real-world clinical impact in terms of improved patient outcomes and efficiency of DR screening would also be valuable.
Conclusion
The OphtAI system demonstrates excellent performance in automatically detecting referable diabetic retinopathy and assessing DR severity from color fundus images. By outperforming the only other FDA-authorized AI system for this task, OphtAI shows promise in streamlining DR screening and improving access to this critical service for people with diabetes. The system's speed and comprehensive capabilities could have a significant impact on early detection and treatment of this leading cause of vision loss.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
🚀
0
Instant automatic diagnosis of diabetic retinopathy
Gwenol'e Quellec, Mathieu Lamard, Bruno Lay, Alexandre Le Guilcher, Ali Erginay, B'eatrice Cochener, Pascale Massin
The purpose of this study is to evaluate the performance of the OphtAI system for the automatic detection of referable diabetic retinopathy (DR) and the automatic assessment of DR severity using color fundus photography. OphtAI relies on ensembles of convolutional neural networks trained to recognize eye laterality, detect referable DR and assess DR severity. The system can either process single images or full examination records. To document the automatic diagnoses, accurate heatmaps are generated. The system was developed and validated using a dataset of 763,848 images from 164,660 screening procedures from the OPHDIAT screening program. For comparison purposes, it was also evaluated in the public Messidor-2 dataset. Referable DR can be detected with an area under the ROC curve of AUC = 0.989 in the Messidor-2 dataset, using the University of Iowa's reference standard (95% CI: 0.984-0.994). This is better than the only AI system authorized by the FDA, evaluated in the exact same conditions (AUC = 0.980). OphtAI can also detect vision-threatening DR with an AUC of 0.997 (95% CI: 0.996-0.998) and proliferative DR with an AUC of 0.997 (95% CI: 0.995-0.999). The system runs in 0.3 seconds using a graphics processing unit and less than 2 seconds without. OphtAI is safer, faster and more comprehensive than the only AI system authorized by the FDA so far. Instant DR diagnosis is now possible, which is expected to streamline DR screening and to give easy access to DR screening to more diabetic patients.
Read more8/27/2024
0
Automated Retinal Image Analysis and Medical Report Generation through Deep Learning
Jia-Hong Huang
The increasing prevalence of retinal diseases poses a significant challenge to the healthcare system, as the demand for ophthalmologists surpasses the available workforce. This imbalance creates a bottleneck in diagnosis and treatment, potentially delaying critical care. Traditional methods of generating medical reports from retinal images rely on manual interpretation, which is time-consuming and prone to errors, further straining ophthalmologists' limited resources. This thesis investigates the potential of Artificial Intelligence (AI) to automate medical report generation for retinal images. AI can quickly analyze large volumes of image data, identifying subtle patterns essential for accurate diagnosis. By automating this process, AI systems can greatly enhance the efficiency of retinal disease diagnosis, reducing doctors' workloads and enabling them to focus on more complex cases. The proposed AI-based methods address key challenges in automated report generation: (1) Improved methods for medical keyword representation enhance the system's ability to capture nuances in medical terminology; (2) A multi-modal deep learning approach captures interactions between textual keywords and retinal images, resulting in more comprehensive medical reports; (3) Techniques to enhance the interpretability of the AI-based report generation system, fostering trust and acceptance in clinical practice. These methods are rigorously evaluated using various metrics and achieve state-of-the-art performance. This thesis demonstrates AI's potential to revolutionize retinal disease diagnosis by automating medical report generation, ultimately improving clinical efficiency, diagnostic accuracy, and patient care. [https://github.com/Jhhuangkay/DeepOpht-Medical-Report-Generation-for-Retinal-Images-via-Deep-Models-and-Visual-Explanation]
Read more8/15/2024
🔎
0
Detecting Severity of Diabetic Retinopathy from Fundus Images: A Transformer Network-based Review
Tejas Karkera, Chandranath Adak, Soumi Chattopadhyay, Muhammad Saqib
Diabetic Retinopathy (DR) is considered one of the significant concerns worldwide, primarily due to its impact on causing vision loss among most people with diabetes. The severity of DR is typically comprehended manually by ophthalmologists from fundus photography-based retina images. This paper deals with an automated understanding of the severity stages of DR. In the literature, researchers have focused on this automation using traditional machine learning-based algorithms and convolutional architectures. However, the past works hardly focused on essential parts of the retinal image to improve the model performance. In this study, we adopt and fine-tune transformer-based learning models to capture the crucial features of retinal images for a more nuanced understanding of DR severity. Additionally, we explore the effectiveness of image transformers to infer the degree of DR severity from fundus photographs. For experiments, we utilized the publicly available APTOS-2019 blindness detection dataset, where the performances of the transformer-based models were quite encouraging.
Read more6/11/2024
🌐
0
Lesion-aware network for diabetic retinopathy diagnosis
Xue Xia, Kun Zhan, Yuming Fang, Wenhui Jiang, Fei Shen
Deep learning brought boosts to auto diabetic retinopathy (DR) diagnosis, thus, greatly helping ophthalmologists for early disease detection, which contributes to preventing disease deterioration that may eventually lead to blindness. It has been proved that convolutional neural network (CNN)-aided lesion identifying or segmentation benefits auto DR screening. The key to fine-grained lesion tasks mainly lies in: (1) extracting features being both sensitive to tiny lesions and robust against DR-irrelevant interference, and (2) exploiting and re-using encoded information to restore lesion locations under extremely imbalanced data distribution. To this end, we propose a CNN-based DR diagnosis network with attention mechanism involved, termed lesion-aware network, to better capture lesion information from imbalanced data. Specifically, we design the lesion-aware module (LAM) to capture noise-like lesion areas across deeper layers, and the feature-preserve module (FPM) to assist shallow-to-deep feature fusion. Afterward, the proposed lesion-aware network (LANet) is constructed by embedding the LAM and FPM into the CNN decoders for DR-related information utilization. The proposed LANet is then further extended to a DR screening network by adding a classification layer. Through experiments on three public fundus datasets with pixel-level annotations, our method outperforms the mainstream methods with an area under curve of 0.967 in DR screening, and increases the overall average precision by 7.6%, 2.1%, and 1.2% in lesion segmentation on three datasets. Besides, the ablation study validates the effectiveness of the proposed sub-modules.
Read more8/15/2024